StockData

OSR Health, Inc. (OSRH) stock

OSRHOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as OSRHW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.21−0.02 (-7.08%)

Close on Oct 19, 2026Market cap $7.60MP/E –Yield –

OSR Health r&d expenses

Research and development expenses are spending on new products and technology.

OSR Health's R&D Expenses for the twelve months ending Sep 30, 2026 was $486.65K. For fiscal 2025 it was $318.45K, up 97.6% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$318.45K+97.6%
FY2024Dec 31, 2024$161.16K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$102.31K+91.1%
Q2 FY2026Jun 30, 2026$94.63K+5.0%
Q1 FY2026Mar 31, 2026$113.15K+681.6%
Q4 FY2025Dec 31, 2025$176.57K+222.8%
Q2 FY2025Jun 30, 2025$53.53K+18.3%
Q1 FY2025Mar 31, 2025$90.15K+93.0%
Q4 FY2024Dec 31, 2024$14.48K–
Q3 FY2024Sep 30, 2024$54.71K–
Q2 FY2024Jun 30, 2024$45.26K–
Q1 FY2024Mar 31, 2024$46.72K–

More OSR Health figures

See a number that looks wrong?